Sign in

Amar Kelkar MD MPH

@amarkelkar.bsky.social
1.4K followers 2.2K following 53 posts

BMT, Gene Therapy, & Hematology Physician at Dana-Farber Cancer Institute, Brigham & Women's Hospital, and Harvard Medical School | AI, Health Policy, Health Economics, & Ethics research | T.H. Chan Harvard MPH ‘23 | SGU '15 | Cornell ‘10

PostsRepliesMedia
Amar Kelkar MD MPH @amarkelkar.bsky.social · 20/12/2025
1/8 Cell and gene therapies (CGT) offer cures, but they are incredibly resource-intensive 🌍 As we consider how to expand access to these therapies to low- and middle-income countries (LMICs), how do we do so ethically and sustainably? 🧵👇 @thelancethaem.bsky.social www.thelancet.com/journals/lan...
thelancet.com
A communitarian approach to cell therapy and gene therapy access in low-income and middle-income countries
In low-income and middle-income countries (LMICs), access to both existing and emerging therapies can be limited. Novel cell and gene therapies (CGT)—such as chimeric antigen receptor T-cell therapies...
110
Amar Kelkar MD MPH @amarkelkar.bsky.social · 20/11/2025
Health care decisions belong with patients and their physicians, not in politics. Grateful for the AMA & @ameracadpeds.bsky.social strong statement affirming evidence-based, gender-affirming care and rejecting harmful misinformation. www.aap.org/en/news-room...
aap.org
AMA and AAP Joint Statement on Evidence-Based Health Care
The American Medical Association (AMA) and the American Academy of Pediatrics (AAP) represent hundreds of thousands of physicians nationwide. Our members provide evidence-based care with a clear, sing...
010
Amar Kelkar MD MPH @amarkelkar.bsky.social · 02/08/2025
The urgency is real—but the “Most Favored Nation” drug pricing policy is unlikely to deliver lasting reform. In @jama.com, @eddiecliff.bsky.social and I propose accelerating and strengthening Medicare drug price negotiation to align prices with value. 🔗 jamanetwork.com/journals/jam...
jamanetwork.com
Reducing Drug Prices—The Most Favored Nation Policy vs Price Negotiation
This Viewpoint discusses the most favored nation policy vs price negotiation for reducing drug prices.
241
Reposted by Amar Kelkar MD MPH
Amar Kelkar MD MPH @amarkelkar.bsky.social · 29/07/2025
New in @jama.com: The 2025 “Most Favored Nation” (MFN) drug pricing policy rightly captures the necessary urgency in lowering US drug costs—but is likely to face fierce opposition. We propose accelerating & improving on Medicare drug price negotiation. jamanetwork.com/journals/jam...
jamanetwork.com
Reducing Drug Prices—The Most Favored Nation Policy vs Price Negotiation
This Viewpoint discusses the most favored nation policy vs price negotiation for reducing drug prices.
152
Amar Kelkar MD MPH @amarkelkar.bsky.social · 29/07/2025
New in @jama.com: The 2025 “Most Favored Nation” (MFN) drug pricing policy rightly captures the necessary urgency in lowering US drug costs—but is likely to face fierce opposition. We propose accelerating & improving on Medicare drug price negotiation. jamanetwork.com/journals/jam...
jamanetwork.com
Reducing Drug Prices—The Most Favored Nation Policy vs Price Negotiation
This Viewpoint discusses the most favored nation policy vs price negotiation for reducing drug prices.
152
Amar Kelkar MD MPH @amarkelkar.bsky.social · 03/07/2025
The House of Representatives is voting into the night on a massive House Resolution (HR) 1 that will result in 16 million losing healthcare coverage (~11 million on Medicaid, and ~5 million from ACA marketplaces). Call your Congressperson's office tonight and tell them to vote NO!
221
Reposted by Amar Kelkar MD MPH
🦋Dr. Natalia🕊🌻🪬 @solnatamd.medsky.social · 03/07/2025
The American Medical Association President Dr. Bobby Mukkamala. @ama-assn.org 💥Medicaid patients will lose access to care if the OBBBA is adopted.💥
411243
Reposted by Amar Kelkar MD MPH
Laurence H. Tribe @tribelaw.bsky.social · 20/06/2025
We are facing a serious threat to democracy, law, and liberty. The abuse of prosecutorial power to intimidate, investigate, and detain political opponents is upon us. It is a constitutional crisis. I will keep speaking out until public outrage overflows. I just hope it’s not too little, too late.
637170295645
Reposted by Amar Kelkar MD MPH
Jack Resneck MD @jackresneckmd.bsky.social · 07/03/2025
A coalition of all 50 state medical associations, representing hundreds of thousands of physicians and their 80 million Medicaid patients, joined to demand that Congress protect #Medicaid from the devastating $880 billion proposed cuts. (link to letter below) www.cmadocs.org/Portals/CMA/...
cmadocs.org
041
Amar Kelkar MD MPH @amarkelkar.bsky.social · 20/06/2025
Nice to see the AMA finally off the sidelines fighting for #Medicaid! Proposed changes (work reqs, cuts, red tape) threaten coverage for millions—esp in rural & underserved areas. Lawmakers must hear us: these cuts would be devastating! #MedicaidIsHealthCare searchlf.ama-assn.org/letter/docum...
searchlf.ama-assn.org
000
Reposted by Amar Kelkar MD MPH
Sherry Pagoto, PhD @drsherrypagoto.bsky.social · 30/05/2025
Viewpoint in JAMA details the consequences of the proposed cuts to NIH: ❌15% reduction in new therapies ❌reduction in life expectancy by 83M life years in the US = $8.2T ❌loss of $51B in economic output annually All to save $20B annually. The math ain't mathin.' jamanetwork.com/journals/jam...
jamanetwork.com
Cutting the NIH—The $8 Trillion Health Care Catastrophe
This JAMA Forum discusses the recent budget cuts to National Institutes of Health (NIH), the effects of these cuts on scientific research and health of individuals in the US, and the prospects for cha...
17665
Reposted by Amar Kelkar MD MPH
Dana-Farber News @danafarbernews.bsky.social · 09/05/2025
In a new @bloodadvances.bsky.social study, @danafarber.bsky.social researchers led by @amarkelkar.bsky.social outline an ethical framework to allocate scarce gene therapies in blood cancers—aiming to balance fairness, need and outcomes. bit.ly/3YBdpTr
bit.ly
Amar Kelkar, MD, MPH
Dana-Farber Cancer Institute
051
Amar Kelkar MD MPH @amarkelkar.bsky.social · 08/05/2025
📢 My new @nejm.org article: "U.S. Research Leadership at a Crossroads" examines the proposed 15% cap on #NIH indirect cost rates (ICRs). This threatens the foundation of US medical research leadership. #NIHfunding 1/6 www.nejm.org/doi/full/10....
nejm.org
U.S. Research Leadership at a Crossroads — The Impact of Reducing NIH Indirect-Cost Coverage | NEJM
The Trump administration’s proposed 15% cap on indirect-cost rates for National Institutes of Health grants risks upending the paradigm that underpins American leadership in medical research.
192
Reposted by Amar Kelkar MD MPH
Randall Munroe @xkcd.com · 25/04/2025
PhD Timeline xkcd.com/3081
5865979220443
Reposted by Amar Kelkar MD MPH
Scott Delaney @scott-delaney.bsky.social · 21/03/2025
The crush of new grant cancellations hasn't let up. If your grant was terminated (or your app was pulled) please use this Google Form👇 to submit details for tracking purposes. Multiple advocacy efforts are moving forward, but we must must must know more about what grants were cancelled and why.
forms.gle
Cancelled NIH grant information submission form
Please use this form to submit information identifying specific NIH grants that have been cancelled for any reason after January 20, 2025. Data from this form will be used to update the Rescinded NIH...
10433492
Reposted by Amar Kelkar MD MPH
Joyce White Vance @joycewhitevance.bsky.social · 11/02/2025
1/ The medical community is fighting back! In the Doctors for America lawsuit in DC, a judge has just ordered that at least for now, HHS, CDC, & FDA must restore public health webpages taken down. by midnight tonight. storage.courtlistener.com/recap/gov.us...
305179784570
Reposted by Amar Kelkar MD MPH
Catherine Rampell @crampell.bsky.social · 08/02/2025
NIH cuts billions of dollars in biomedical funding, effective immediately. The move halts a large slice of money for most universities and research institutions virtually overnight, imperiling vital research in everything from cancer to heart disease. www.washingtonpost.com/health/2025/...
washingtonpost.com
NIH cuts billions of dollars in biomedical funding, effective immediately
The move halts a large slice of money for most universities and research institutions virtually overnight, imperiling vital research in everything from cancer to heart disease.
31348311865
Reposted by Amar Kelkar MD MPH
Medsky Moderation @moderation.medsky.network · 14/01/2025
You can also search for your specialty using the Medsky Labeler catalog. Click on "Link to Post" next to your specialty of choice to navigate to the appropriate labeling post.
tinyurl.com
Medsky.Social Catalog
372
Reposted by Amar Kelkar MD MPH
Jon Cooper @joncooper-us.bsky.social · 26/01/2025
Scientists at the National Institutes of Health have been told the communications pause announced by the Trump Administration earlier this week includes a pause on ALL purchasing — including supplies for their ongoing research to treat cancer, Alzheimer’s, heart disease and many infectious diseases.
cnn.com
Scientists at NIH can’t purchase supplies for their studies after Trump administration pauses outside communications | CNN
Scientists at the National Institutes of Health have been told the communications pause announced by the Trump Administration earlier this week includes a pause on all purchasing, including supplies f...
1591719845
Reposted by Amar Kelkar MD MPH
🦋Dr. Natalia🕊🌻🪬 @solnatamd.medsky.social · 20/01/2025
Dictatorial political regimes always weaponize medical care against the people they target. Doctors have ethical obligations to their patients, but dictators do not care about these obligations. They care only about doctors' loyalty to the political regime. No paywall archive.ph/un1Lu
nytimes.com
Opinion | Doctors and Nurses Should Get Ready for Mass Deportations
Doctors have a responsibility to reassure their patients, regardless of immigration status, that they are welcome and protected.
415975
Reposted by Amar Kelkar MD MPH
Eric Lipton NYT @ericlipton.nytimes.com · 20/01/2025
To put Trump's new crypto business into context, here is an illustrated guide we published on Friday that details the full range of apparent conflicts of interest as Trump enters the White House again. A good reference work. www.nytimes.com/interactive/....
nytimes.com
An Illustrated Guide to Trump’s Conflict of Interest Risks (Gift Article)
President-elect Donald J. Trump has a range of new business ventures that could expose him to even greater potential conflicts of interest than during his first term.
22445162
Reposted by Amar Kelkar MD MPH
NEJM.org @nejm.org · 06/12/2024
Hello, #MedSky community! We’re excited to begin our Bluesky journey. Here is a sampling of the trusted, influential, and essential information you can expect when you follow us:
32860187
Reposted by Amar Kelkar MD MPH
American Society of Hematology @ash.hematology.org · 11/12/2024
Thank you to everyone who shared their #ASH24 #ASHaiku 🙏🎉 Who else enjoys this tradition? Here's a thread of some of our favorites! 🧵 #HemeSky #Hematology
1192
Amar Kelkar MD MPH @amarkelkar.bsky.social · 11/12/2024
Part 2 on allogeneic stem cell transplantation for AML with The Fellow On Call pod dropped today! Hope y'all find it helpful! #BMTsm #AMLsm #MedSky #HemeSky open.spotify.com/episode/1CQM...
open.spotify.com
Episode 124: AML Series, Pt 10 - Allogeneic transplant for AML
The Fellow on Call: The Heme/Onc Podcast · Episode
051
Amar Kelkar MD MPH @amarkelkar.bsky.social · 07/12/2024
I swear we didn’t pose this 😆 but now all I can think of is the Spiderman pointing meme …
140
Amar Kelkar MD MPH @amarkelkar.bsky.social · 06/12/2024
Glad to join The Fellow On Call crew to talk #BMTsm for AML on this week’s episode! The whole AML series has been excellent review! @ronakmistrydo.bsky.social open.spotify.com/episode/6BAs...
open.spotify.com
Episode 123: AML Series, Pt 9 - Introduction to Allogeneic Transplant
The Fellow on Call: The Heme/Onc Podcast · Episode
051
Reposted by Amar Kelkar MD MPH
American Society of Hematology @ash.hematology.org · 29/11/2024
8 days ago, ASH decided to join Bluesky. 🌤️ So far, we're enjoying fewer distractions & more meaningful connections. 💬 Engaging with our amazing #hematology and #hemeonc communities has never been easier. We created an #ASH24 feed for you & we have more feeds coming soon: bit.ly/ASH24feed #Hemesky
112126
Reposted by Amar Kelkar MD MPH
American Society of Hematology @ash.hematology.org · 03/12/2024
📹 Make the most of the ASH Annual Meeting — here's what you need to know before you go! www.youtube.com/watch?v=QGDX... Learn about registration hours and locations, download the #ASH24 app, & preview the virtual platform and the new food guide! 😋🍔Check your email. #HemeSky #Hematology
youtube.com
Know Before You Go: 66th ASH Annual Meeting and Exposition
YouTube video by American Society of Hematology
1217
Amar Kelkar MD MPH @amarkelkar.bsky.social · 04/12/2024
Happy Fellowship Match Day to all those who were applying this cycle! It’s always a nerve wracking time of year and I hope everyone got some clarity regardless of outcomes. For any inbound hematologists and oncologists, welcome!! #medsky #hemesky
media.tenor.com
a bald man in a blue suit is making a gesture with his hands .
ALT: a bald man in a blue suit is making a gesture with his hands .
050
Reposted by Amar Kelkar MD MPH
Shematologist, MD @shematologist.medsky.social · 26/11/2024
Why did the banana go to the doctor? Because it wasn’t peeling well. Food jokes are funny, hunger is not. Join us in #HCWvsHunger 11/28-12/3 HCWvsHunger.org
hcwvshunger.org
Healthcare Workers vs Hunger
Healthcare workers vs Hunger is an annual friendly competition between teams of healthcare workers to help relieve food insecurity.
310829
Reposted by Amar Kelkar MD MPH
Eddie Cliff @eddiecliff.bsky.social · 16/11/2024
Just out at JAMA Oncology, led by Parsa Erfani We review why many efforts to improve access to oncology medicines around the world have failed so far, especially compared to infectious diseases, & offer potential strategies to improve global pharmacoequity jamanetwork.com/journals/jam...
042
Reposted by Amar Kelkar MD MPH
Ben Rome @benro.me · 21/11/2024
And for more detail, check out the Perspective article by me, @akesselheim.bsky.social, and @wbfeldman.bsky.social. www.nejm.org/doi/full/10....
042
Reposted by Amar Kelkar MD MPH
Program On Regulation, Therapeutics, And Law (PORTAL) @handle.invalid · 21/11/2024
📣PORTAL is hiring! 📣 There are less than 2 weeks left to apply for our Postdoctoral and General Medicine Fellowships, both with a focus on pharmaceutical law, health policy, and health services research. Apply by December 1, 2024. Learn more: mailchi.mp/3e02f38a708b/portal-hiring-2025
mailchi.mp
Deadline Approaching - Join the PORTAL Team!
Apply by December 1, 2024 to be a PORTAL Postdoctoral or General Medicine Fellow. We are also accepting applications for a Faculty Member in Health Policy or Health Services Research.
144
Reposted by Amar Kelkar MD MPH
William Feldman @wbfeldman.bsky.social · 25/11/2024
New paper out at @jamacurrent.bsky.social led by @ojwouters.bsky.social on the empirical assumptions underlying differential protection for biologics & small-molecule drugs. Upshot: We found no good evidence supporting differential treatment by FDA (or under IRA). jamanetwork.com/journals/jam...
jamanetwork.com
Legal Protections for Biologics vs Small-Molecule Drugs in the US
This Special Communication analyzes and compares development times, clinical trial success rates, research and development costs, patent protection, market exclusivity periods, revenues, and treatment...
0106
Amar Kelkar MD MPH @amarkelkar.bsky.social · 23/11/2024
This is going to be looked back on as a highly ineffective statement, but it, like most of the society letters we’ve seen so far suffer most from not knowing who their audience is. Is the letter to the membership, the public, or the incoming administration?
120
Reposted by Amar Kelkar MD MPH
Jérémy Cours 🌳 @jeremycours.bsky.social · 23/11/2024
First post on Bluesky, let’s share some websites offering many free illustrations for scientific figures 🖼️ 🧪 🌍 : scidraw.io bioart.niaid.nih.gov www.phylopic.org More well known but very nice though: www.freepik.com
scidraw.io
SciDraw | Scientific Drawings
SciDraw - an open repository of science drawings
57901224
Reposted by Amar Kelkar MD MPH
Brent Weinberg @brentweinberg.bsky.social · 22/11/2024
If you're new here and wondering how to get your feed going, check out the directory of all "starter packs", or lists of people you can follow in bulk. Try searching for your topic of interest and follow the ones you like blueskydirectory.com/starter-pack...
blueskydirectory.com
Bluesky Starter Packs - Bluesky Directory
Browse a list of Bluesky Starter Packs. Discover and connect with your community on Bluesky
072
Reposted by Amar Kelkar MD MPH
Shikha Jain MD FACP @shikhajainmd.bsky.social · 19/11/2024
Trying my hand at a starter pack. #OncSky #MedOnc #womeninoncology #HemeOnc #hemeSky #MedSky go.bsky.app/4pWmu3W
7375
Reposted by Amar Kelkar MD MPH
Kyle Swanson, MD, FAANS, FCNS @kiswanson.medsky.network · 19/11/2024
Looking for medical professionals to follow? Just added the 6th installment *Medsky Sanguine Six* #medsky 🩺🧪 Round 1 go.bsky.app/Qg2TA9p Round 2 go.bsky.app/9ziyYqt Round 3 go.bsky.app/9WQtZh6 Round 4 go.bsky.app/HRaNhEt Round 5 go.bsky.app/DvGjDh6 Round 6 go.bsky.app/TzRhec3
8026993
Reposted by Amar Kelkar MD MPH
Dr. Richard Pan @drpanmd.bsky.social · 21/11/2024
My statement on Trump's nomination of RFK Jr. & Mehmet Oz to lead federal health agencies HHS and CMS. #science
48849